$INCC - Summary of Trading - As At May 11 Close.
$INCC - Summary of Trading - As At May 11 Close.
Loading in .0002>.0013 range since last at .0001 x .0002:
.0002: 93M
.0003: 63M
.0004: 176M
.0005: 51M
.0006: 25M
.0007: 3M
.0008: 18M
.0009: 9M
.0010: 16M
.0011: 19M
.0012: 17M
.0013: 8M
Total: 498M to close on November 4.
November 7: 147M .0013 >.0025
November 8: 170M .0016 > .0033
November 9: 114M .0024 > .0011
November 10: 100M .0016 > .0008
November 11: 110M .0005 > .0010
November 14: 55M .0011 > .0015
November 15: 55M .0013 > .0021
November 16: 101M .0013 > .0025
November 17: 29M .0016 > .0023
November 18: 21M .0015 > .0019
November 21: 32M .0010 > .0017
November 22: 20M .0011 > .0017
November 23: 15M .0013 > .0017
November 25: 5M .0013 > .0017
November 28: 6M .0013 > .0016
November 29: 8M .0013 > .0016
November 30: 6M .0012 > .0015
December 1: 4M .0013 >.0015
December 2: 9M .0014 > .0016
December 5: 5M .0012 > .0016
December 6: 3M .0013 > .0015
December 7: 24M .0014 > .0016
December 8: 9M .0014 > .0017
December 9: 5M .0014 > .0016
December 12: 6M .0014 > .0016
December 13: 3M .0014 > .0016
December 14: 10M .0014 > .0015
December 15: 3M: .0013 > .0015
December 16: 7M .0013 > .0015
December 19: 5M .0013 > .0015
December 20: 3M .0013 > .0015
December 21: 5M .0013 > .0015
December 22: 5M .0013 > .0015
December 23: 12M .0013 > .0015
December 27: 93M .0014 > .0018
December 28: 42M .0015 > .0018
December 29: 48M .0015 > .0018
December 30: 42M .0014 > .0019
January 3: 68M .0013 > .0019
January 4: 9M .0014 > .0017
January 5: 68M .0012 > .0017
January 6: 11M .0012 > .0015
January 9: 23M: .0012 > .0017
January 10: 21M .0012 > .0015
January 11: 8M .0012 > .0015
January 12: 12M .0012 > .0014
January 13: 11M .0012 > .0014
January 17: 44M .0012 > .0014
January 18: 35M .0011 > .0014
January 19: 9M .0012 >.0013
January 20: 21M .0010 > .0013
January 23: 40M .0008 > .0013
January 24: 13M .0008 > .0010
January 25: 9M .0009 > .0010
January 26: 13M .0009 > .0011
January 27: 9M .0009 > .0011
January 30: 10M .0010 > .0012
January 31: 7M .0010 > .0012
February 1: 15M .0009 > .0011
February 2: 11M .0009 > .0010
February 3: 14M .0009 > .0010
February 6: 6M .0009 > .0010
February 7: 6M .0009 > .0010
February 8: 5M .0009 > .0010
February 9: 98M .0009 > .0014
February 10: 34M .0011 > .0014
February 13: 19M .0009 > .0014
February 14: 11M .0009 > .0011
February 15: 17M .0010 > .0012
February 16: 8M .0011 > .0012
February 17: 7M .0010 > .0012
February 21: 5M .0010 > .0012
February 22: 4M .0010 > .0012
February 23: 10M .0010 > .0011
February 24: 37M .0008 > .0010
February 27: 19M .0008 > .0010
February 28: 3M .0008 > .0009
March 1: 7M .0008 > .0009 [discounting .0005 paint below bid]
March 2: 14M .0007 > .0009
March 3: 4M .0007 > .0008
March 6: 7M .0008 [discounting token paint down of 10K at .0007]
March 7: 9M .0007 > .0009
March 8: 4M .0007 > .0009
March 9: 4M .0008 > .0009
March 10: 2M .0008 > .0009 [discounting .0007 paint below bid]
March 13: 3M .0007 > .0009
March 14: 2M .0007 > .0008
March 15: 2M .0007 > .0009
March 16: 7M .0007 > .0008
March 17: 2M .0007 > .0008
March 20: 5M .0007 > .0008
March 21: 2M .0007 > .0008
March 22: 32M .0006 > .0008
March 23: 15M .0007 > .0008
March 24: 4M .0007 > .0009 [discounting paint down below bid at open]
March 27: 1M .0007 > .0008 [discounting paint down below bid at open]
March 28: 7M .0007 > .0008
March 29: 7M .0006 > .0008
March 30: 4M .0006 > .0008
March 31: 8M .0006 > .0008
April 3: 124M .0005 > .0007
April 4: 8M .0005 > .0006
April 5: 10M .0006 > .0007
April 6: 2M .0006 > .0007
April 7: 3M .0006 >.0007
April 10: 1M .0005 > .0006
April 11: 2M .0005 > .0006
April 12: 1M .0005 > .0006
April 13: 7M .0005 > .0007
April 17: 3M .0005 > .0007
April 18: 13M .0005 > .0006
April 19: 1M: .0005 > .0006
April 20: 2M .0005 > .0006
April 21: 3M .0005 > .0007
April 24: 4M .0005 > .0007
April 25: 2M .0005 > .0007
April 27: 3M .0005 > .0007
April 28: 2M .0006 > .00078
May 1: 3M .0006 > .0007
May 2: 1M .0005 > .0006
May 3: 7M .0005 > .0007
May 4: 2M .0006 > .0007 [discounting paint down at .0005 below bid]
May 5: 7M .0006 > .0007
May 8: 4M .0006 > .0007
May 9: 3M .0006 > .0007
May 10: 1M .0006 > .0007
May 11: 4M .0006 > .0007
May 12: 1M .0006 > .0007
May 15: 2M .0006 > .0007
Total loaded so far in May: 35M in the last 11 trading days.
Total since my alert at .0001 x .0002: 2.988B
Tersis Technologies, Inc. (TERS) Stock Research Links
"Per Ardua Ad Astra" - "Through Adversity To The Stars"
A very apposite motto for those who trade successfully in the OTC market..
All posts are my opinion - trade at your own risk.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Turning Heads with a Rich Pour Forget watering down—Blade and Bow's latest masterpiece, the 30-Year-Old Cask Strength Kentucky Straight Bourbon Whiskey, is all about power. This new offering hasn't seen a drop of water since it left the barrel, clocking in at a punchy 164.2 proof. That's right, folks, they haven't pulled any punches this time. Heading into November,...
Continue Reading
Deer Season's Bumper Problem If you're driving a hefty pickup or van in the thick of deer season, forget looking at pretty autumn leaves. Instead, brace for the telltale thud—and the ensuing financial headache—that comes with a deer collision. Anyone who's tangled with such a mishap knows it's not just about the dent in your fender; it's about your wallet getting...
Continue Reading
A Look at Where Policies Stumble Life's got no script for chaos, and you'd think the laws meant to protect folks from domestic violence would at least have a solid plan. Turns out, that's not always the case. Bloomberg Law just pulled back the curtain in a stinging investigation that exposes the gaping holes in these well-meaning policies. Why spill my morning coffee over...
Continue Reading
The True Stories Behind Exorcisms In the complex landscape of media today, EWTN Studio's latest docuseries, In Jesus' Name, steps into the ring with tales that outstrip Hollywood's beloved fright flicks. Forget about the jumpscares and the special effects next to those greased-up eggs you're munching on. This series drills right to the bone of reality—a candid look at...
Continue Reading
Breathing New Life into a Brooklyn Classic Alright, picture this: You're stepping into a century-old Brooklyn loft, expecting dust, aged wood, maybe a ghost or two. What you actually find is art wrapped in brass with a splash of modern flair. This ain't just any loft, folks—it's the latest trophy on the mantle for Gallery KBNY, a design-build firm known for its...
Continue Reading
It seems the digital world and power supply have locked in a new dance as DayOne Data Centers teams up with Sembcorp Utilities. It's high time we gave this story a solid look, especially with data centers gobbling energy faster than my old trading partner downs an espresso. Tackling Energy Constraints Head-On The digital infrastructure beast is hungry for power, and...
Continue Reading
New Awards Shine Light on Corporate Legal Teams Here's one for the books: Bloomberg Law is rolling out a shiny new awards program called Inside In-House: Legal Departments of the Year. Now, this isn't some vanity affair because it's aimed at celebrating the folks in legal teams who make companies tick behind the scenes. Openings for nominations run through November 20,...
Continue Reading
The Unicycive Landslide: What Went Down? Investors, buckle up. Unicycive Therapeutics Inc. (NASDAQ: UNCY) finds itself deep in the muck of a securities class action. Chief honchos, CEO Shalabh Gupta and CFO John Townsend, are taking the heat for allegedly controlling company disclosures that led shareholders to believe in non-existent progress with their third-party...
Continue Reading
Championing Banking Innovations Globally If there's one thing you can count on in the financial world, it's innovation pushing the boundaries of how we bank. The 13th edition of the Qorus-Infosys Finacle Banking Innovation Awards has once again proven that innovation is not just a buzzword but a real, transformative force in the global banking landscape. This year, they...
Continue Reading
Pozdeutinurad's Phase 3 Triumph Ah, the life of biotech—constant ups and downs, but when you hit a homerun, it feels like the market stands still for a second. Pozdeutinurad's recent Phase 3 REDUCE-2 study results are one of those moments for Swedish Orphan Biovitrum AB, or Sobi for short. This study showed some seriously compelling data: clinically meaningful and...
Continue Reading
Top 5 Most Recently Viewed Articles
Clarametyx Biosciences Partners with CARB-X Clarametyx Biosciences Inc, a pioneering biotechnology firm, is making strides in the fight against bacterial infections linked to biofilms. Recently, the company announced a significant partnership with CARB-X (Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator), an essential player in supporting...
Continue Reading
Introduction to Nvidia and Intel's Partnership In a groundbreaking development, shares of Intel Corp. witnessed a remarkable surge of 28%. This significant increase came after Nvidia Corp. announced an impressive $5 billion investment in Intel. This partnership aims to revolutionize the semiconductor landscape profoundly, signaling a critical turning point within the...
Continue Reading
Overview of the Data Breach Incident In recent news, Wayne Memorial Hospital has disclosed a significant data breach that has affected a large number of individuals. This hospital, well-known for providing a wide array of medical services, encountered a cybersecurity incident that compromised a vast range of sensitive personal information. The hack involved unauthorized...
Continue Reading
Investigation Launched for PDD Holdings Investors Faruqi & Faruqi, LLP, a well-known firm in national securities law, is reaching out to investors of PDD Holdings who have suffered significant losses. If your losses exceed $100,000, don’t wait any longer—contact Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310) to explore your options. What’s...
Continue Reading
Raising Awareness About Prostate and Urological Health Men's health issues, particularly those related to prostate and urological functions, often remain shrouded in silence. This silence can be detrimental, as it can lead to late diagnoses and increased mortality rates. One key initiative aimed at combating this issue is the campaign from Mediaplanet, dedicated to urging...
Continue Reading